Kathryn Ruddy, MD, Professor of Oncology and Consultant for the Division of Medical Oncology at the Mayo Clinic, Rochester, MN
Kathryn J. Ruddy, MD MPH is a Professor of Oncology and Consultant for the Division of Medical Oncology at Mayo Clinic in Rochester, MN. As a medical oncologist who specializes in patients with breast cancer, she has particular expertise in male breast cancer, as well as managing side effects of treatment, pre-menopausal breast cancer and survivorship issues including fertility.
In addition to her clinical activities, Dr. Ruddy co-leads the Mayo Clinic Comprehensive Cancer Center (MCCCC) Cancer Prevention, Control, and Survivorship Program. She also leads the Population Sciences and Community Interventions Disease Group for MCCCC. Nationally, she is a Fellow of the American Society of Clinical Oncology (FASCO), an Associate Editor of the Journal of the National Cancer Institute, and a member of the Breast Cancer Steering Committee of the National Cancer Institute. She mentors residents and fellows, speaks at national meetings, and publishes in high-impact scientific journals.
Dr. Ruddy is active in research focused on prediction and prevention of toxicity in patients with cancer, and on patient-reported outcomes during and after cancer treatment. She studies the long-term and late effects of cancer treatments, and how best to care for cancer survivors to enhance their quality of life and reduce symptoms.